Etcamah now joins Roche’s rival…
Etcamah now joins Roche’s rival oral SERD, giredestrant, in missing [...]
How Did a Heart Drug With So Much Promise Fall So Flat?
Cardiologists are struggling to figure out why a drug that [...]
Following formal sign-off from the…
Following formal sign-off from the FDA, Handa Pharmaceuticals’ branded drug [...]
Revolution Medicines recently made…
Revolution Medicines recently made history with the approval of its [...]
Takeda’s long-time R&D chief…
Takeda’s long-time R&D chief Andy Plump will retire. Daiichi Sankyo [...]
Argonaut Manufacturing Services, a…
Argonaut Manufacturing Services, a CDMO specializing in aseptic fill-finish for [...]
In his first interview after…
In his first interview after taking the reins of the [...]
Officials rubbed shoulders with…
Officials rubbed shoulders with business leaders in a 19th-floor meeting [...]
Takeda President of Research and…
Takeda President of Research and Development Andy Plump, M.D., Ph.D., [...]
With positive phase 3 results in…
With positive phase 3 results in hand, AbbVie is one [...]